Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of deferiprone in Parkinson's disease
2011-001148-31Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of deferiprone in Parkinson's disease (PD), sponsored by Imperial College London. Primary endpoints: Reduction of excess brain iron in the substantia nigra and Tolerability and safety. Started Aug 2011; status: completed.
02
Drugs
deferiprone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2011-001148-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001148-31.